Please login to the form below

Not currently logged in
Email:
Password:

drug development

This page shows the latest drug development news and features for those working in and with pharma, biotech and healthcare.

Entering the era of digital trials

Entering the era of digital trials

If sponsors can clear the remaining bottlenecks, the era of end-to- end digital drug development will begin. ... End-to-end digital drug development is coming. The question is how soon. .

Latest news

  • Novartis: pipeline will generate 60 filings in three years Novartis: pipeline will generate 60 filings in three years

    Novartis' new drug development head John Tsai. Both these drugs have “the potential to change the standard of care, ”according to the company. ... Taking centre stage at the presentation will be John Tsai, the company's new head of global drug

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    could speed up the process of drug development tenfold, according to the RFI. ... The company’s CEO, Ken Mulvany, has said he. thinks the AI platform can cut early-stage drug discovery by four years and potentially deliver efficiencies in the entire

  • Genomics England partners with Congenica for genome service Genomics England partners with Congenica for genome service

    The 100, 000 Genomes Project has broad potential, and could be used to help accelerate drug discovery and development.

  • Labour party divided on Brexit ‘People’s Vote’ Labour party divided on Brexit ‘People’s Vote’

    Roche has 2, 100 employees in the UK, including in drug development. ... It goes without saying that we give preference in research and development activities where we bring the medicines to patients first, ”Schwan said.

  • Boehringer’s Corsico to be new GSK drug dev leader Boehringer’s Corsico to be new GSK drug dev leader

    Boehringer’ s Corsico to be new GSK drug dev leader. Research and drug development will be split into separate divisions. ... The company told Endpoints News that it will be restructuring its R&D organisation, with Corsico heading up a separate drug

More from news
Approximately 21 fully matching, plus 913 partially matching documents found.

Latest Intelligence

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    Key considerations for disease- modifying Parkinson’ s disease trials. ‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’. ... By Dr Peter Schueler, Senior Vice President, Drug Development Services and Haichen

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Nevertheless, despite this and the usual caveats about the unpredictability of drug development, Pfizer currently has one of the strongest pipelines in the sector. ... One potential major product launch for 2019 will be novel pain drug tanezumab.

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    In major construction projects, like drug development, things don’t always run to plan. ... Co-locating scientists who work on chemistry and small molecule drug development with scientists who work on biologics, large molecules and protein based

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    with the State Development Investment Corporation (SDIC) to set up Dizal Pharma, a joint venture dedicated to the research and development of new medicines. ... A drug which can take development of China’s R&D base to the next level is roxadustat, a

  • Stakeholder dialogue in Europe’s adaptive pathways pilot Stakeholder dialogue in Europe’s adaptive pathways pilot

    So, what have we learned from the experience? Principle 1. Discussions of the drug development plan emphasised assessing the feasibility of the proposed methodology for delivering the required data. ... in small populations. Effectiveness and long-term

More from intelligence
Approximately 6 fully matching, plus 95 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries. ... Atkins said: “Britten joins our Senior Management team at a pivotal time in the Company’s development.

  • Industry round up: appointments Industry round up: appointments

    activities and continues to advance its lead drug candidate, XF-73, through clinical development.”. ... Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28

  • Weekly industry appointments Weekly industry appointments

    approval. Prior to this, Appleby served as project leader and portfolio manager at the GSK Centre of Excellence for External Drug Development. ... Commenting on the new appointment, Keith Thompson, chief executive of CGT Catapult, said: “With over 20

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    Corcoran’s career history has seen him supervise drug development across multiple therapeutic areas including neurology and psychiatry. ... development. “We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases

  • Concept Life Sciences adds to its team Concept Life Sciences adds to its team

    Integrated drug discovery, development and analytical services company Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley Park unit based in Cheshire, UK. ... She said: “I am looking forward to applying my own drug

More from appointments
Approximately 1 fully matching, plus 167 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics